• Publications
  • Influence
Apixaban versus warfarin in patients with atrial fibrillation.
BACKGROUND Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor thatExpand
  • 4,484
  • 149
  • PDF
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
99mTc : technetium-99m 201TI : thallium 201 ABCB1 : ATP-binding cassette sub-family B member 1 ABI : ankle-brachial index ACC : American College of Cardiology ACCF : American College of CardiologyExpand
  • 3,202
  • 121
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
Background— Limited data exist on trends in incidence of atrial fibrillation (AF). We assessed the community-based trends in AF incidence for 1980 to 2000 and provided prevalence projections to 2050.Expand
  • 2,158
  • 85
Strategies for multivessel revascularization in patients with diabetes.
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronaryExpand
  • 1,314
  • 71
  • PDF
Bivalirudin during primary PCI in acute myocardial infarction.
BACKGROUND Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducingExpand
  • 1,706
  • 64
  • PDF
Clinical Features, Management, and Prognosis of Spontaneous Coronary Artery Dissection
Background— Spontaneous coronary artery dissection (SCAD) is an acute coronary event of uncertain origin. Clinical features and prognosis remain insufficiently characterized. Methods and Results— AExpand
  • 587
  • 57
  • PDF
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice
Bernard J. Gersh, MB, ChB, DPhil, FACC, FAHA, Co-Chair*†; Barry J. Maron, MD, FACC, Co-Chair*†; Robert O. Bonow, MD, MACC, FAHA‡; Joseph A. Dearani, MD, FACC§ ; Michael A. Fifer, MD, FACC, FAHA*†;Expand
  • 640
  • 48
  • PDF
The effect of race and sex on physicians' recommendations for cardiac catheterization.
BACKGROUND Epidemiologic studies have reported differences in the use of cardiovascular procedures according to the race and sex of the patient. Whether the differences stem from differences in theExpand
  • 1,685
  • 37
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation
Background—We tested the hypothesis that patients with untreated obstructive sleep apnea (OSA) would be at increased risk for recurrence of atrial fibrillation (AF) after cardioversion. Methods andExpand
  • 830
  • 30
  • PDF